US pharma major Eli Lilly today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase III clinical trials ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...

Using a hybrid, closed-loop insulin delivery system in the auto mode shows improved glycemic control and a favorable safety ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials ...

Asian and Pacific Islander adolescents who are overweight or obese are twice as likely as their white peers to have ...

Cataract surgery is the most commonly performed eye surgery in the ophthalmology, with a track record of improving vision and ...

I read your recent column on A1C levels. You said that 7% to 7.5% was ideal for most people. For older people, you said 8% can be good. My longstanding understanding of A1C levels is that less than 5.

In the realm of diabetes management and diagnosis, two tests often come into focus: the fasting glucose test and the A1c test. Both are crucial tools in assessing blood sugar levels, but they serve ...

Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...

LifeSouth blood donors can now discover their risk for diabetes through a unique opportunity. LifeSouth Community Blood ...